Advertisement

July 8, 2020

Balt's Silk Vista Flow Diverter Approved in Europe

July 8, 2020—Balt announced it has received European CE Mark approval for its Silk Vista flow diverting stent to treat patients with unruptured intracranial aneurysms. The Silk Vista device, which is designed for predictable, accurate deployment and high visibility under angiography, joins the company's lower-profile Silk Vista Baby flow diverter that received CE Mark in 2018.

The first-in-human procedure with Silk Vista was performed in June 2020 by Vitor Mendes Pereira, MD, an endovascular neurosurgeon and Professor of Medical Imaging and Surgery at the University of Toronto in Toronto, Ontario.

“Balt introduced the Silk Vista Baby 2 years ago, a first-in-class flow diverter device for the treatment of distal aneurysms with the benefits of excellent visibility and device deployment,” commented Dr. Mendes Pereira in the company's announcement. “Now, with Silk Vista, Balt has provided physicians the same outstanding deliverability and visibility for the treatment of aneurysms arising off of neurovascular vessels 3.5 mm and larger, while managing to keep the device compatible with a very low profile 0.021-inch microcatheter.”

Advertisement


July 13, 2020

Study Evaluates Rivaroxaban Versus Warfarin in Obese Patients With Acute VTE

July 8, 2020

AHA and ISTH Outline VTE Research Priorities